Process
The clinical practice guidelines constitute a reliable summary of the results of systematic reviews and clinical practice. The development of high quality, well formulated recommendations requires clearly defined procedures which will constitute a source of clear instructions.
Processes and methods adopted by the Agency for:
- issuing opinions on clinical practice guidelines;
- developing guidelines
are based on internationally recognised methodologies, standards and tools designed to ensure the highest quality of the prepared studies.
*Ladies and Gentlemen
We inform you that the materials and results of the discussions posted on the Agency’s website are the result of the conceptual work and analytical process carried out by the team of the Agency for Health Technology Assessment and Tariff System based on the EBM paradigm, including: search, selection, synthesis and interpretation of scientific evidence, or the data analysis carried out.
In connection with the above, we would like to inform you that the use of analytical material or the results of the discussion, in accordance with good practice, should be accompanied by information on the source in the form: [title of presentation / report], AOTMiT, Warsaw, June 2024]